Tsang Nichol Chun Wai, Acharya Aneesha, Pelekos Georgios
Division of Periodontology and Implant Dentistry, Faculty of Dentistry, The University of Hong Kong, Hong Kong SAR, China.
Dr. D. Y. Patil Dental College & Hospital, Dr. D. Y. Patil Vidyapeeth, Pimpri, Pune 411018, India.
Dent J (Basel). 2025 May 22;13(6):228. doi: 10.3390/dj13060228.
Barrier membranes (BMs) have been used in dental surgical procedures for decades, but their exposure can increase the risk of infections and compromise healing from regenerative procedures. Liquid-leukocyte platelet-rich fibrin (LPRF) products have shown antimicrobial effects and enhance wound healing. This in vitro study aimed to evaluate the antimicrobial effects and cellular responses of LPRF products as adjunctive treatments for barrier membranes, hypothesizing that the two liquid LPRF products could improve antibacterial activity against selected oral pathogen species and augment human gingival fibroblast cellular proliferation on BM. LPRF exudate (LPRF-EX) and liquid fibrinogen (PLyf), human LPRF products, were prepared with recommended centrifugation protocols and used to treat resorbable (Bio-gide) and non-resorbable (Cyto-plast™) BMs. Human gingival fibroblasts (HGFs) were cultured on the treated and untreated BMs. Scanning electron microscopy (SEM) was applied to observe cell adhesion, and CCK-8 assays were used to study cell proliferation. Oral and were incubated with the BMs. Bacterial adhesion was visualized using SEM, and colony-forming unit (CFU) counts were obtained. SEM images showed markedly greater fibrin network formation after 7 days on resorbable BM (Bio-gide) treated with PLyF, but with no notable differences in other resorbable BM or non-resorbable BM groups with both treatments. CCK-8 assays showed non-significant effects on HGF proliferation at 3 and 5 days. SEM showed growth inhibition in the LPRF-EX- and PLyf-treated BMs, and the greatest reduction in CFU counts of both and was noted with treated Cytoplast™. Within the limitations of this preliminary study, it can be concluded that the LPRF-EX and PLyf treatment of BM induced an antimicrobial effect. Their effects on cellular response were unclear due to the lack of significant findings on SEM analysis.
屏障膜(BMs)已在牙科手术中使用了数十年,但其暴露会增加感染风险并影响再生手术的愈合效果。富含液体白细胞的富血小板纤维蛋白(LPRF)产品已显示出抗菌作用并能促进伤口愈合。本体外研究旨在评估LPRF产品作为屏障膜辅助治疗的抗菌效果和细胞反应,假设两种液体LPRF产品可提高对选定口腔病原体的抗菌活性,并增强人牙龈成纤维细胞在屏障膜上的细胞增殖。按照推荐的离心方案制备了人LPRF产品LPRF渗出液(LPRF-EX)和液体纤维蛋白原(PLyf),并用于处理可吸收(Bio-gide)和不可吸收(Cyto-plast™)屏障膜。将人牙龈成纤维细胞(HGFs)培养在经处理和未经处理的屏障膜上。应用扫描电子显微镜(SEM)观察细胞黏附情况,并使用CCK-8法研究细胞增殖。将口腔细菌与屏障膜一起孵育。使用SEM观察细菌黏附情况,并获得菌落形成单位(CFU)计数。SEM图像显示,在用PLyF处理的可吸收屏障膜(Bio-gide)上培养7天后,纤维蛋白网络形成明显更多,但在其他可吸收屏障膜或两种处理的不可吸收屏障膜组中没有显著差异。CCK-8法显示在第3天和第5天对HGF增殖无显著影响。SEM显示LPRF-EX和PLyf处理的屏障膜有生长抑制作用,并且在用处理过的Cyto-plast™处理时,两种细菌的CFU计数减少最多。在这项初步研究的局限性内,可以得出结论,LPRF-EX和PLyf处理屏障膜可诱导抗菌作用。由于在SEM分析中缺乏显著发现,它们对细胞反应的影响尚不清楚。